The administration expects to stop buying vaccines and treatment by year’s end, handing over these responsibilities to for-profit companies that are salivating at the opportunity.

New medicines are on the way in the fight against the pandemic, but these life-saving drugs might get trapped in a maze of bad policy.

Why are so many people drawn to stories and videos of the unvaccinated dying of Covid-19—and, at the final moment, wishing for the vaccine?

At long last, the White House is acknowledging that America can’t afford to respect personal choices in a pandemic.

The delta variant is dangerous. A third vaccine dose could be helpful for those with weaker immune systems, but giving third doses to healthy people would be wildly counterproductive.

Not long ago, life-saving medical know-how was viewed as belonging to everyone. What happened?

Through his hallowed foundation, the world’s de facto public health czar has been a stalwart defender of monopoly medicine.

The timing of the announcements, and their lack of detail, are raising worries about insider trading and unrealistic expectations.

Experts celebrated the news that Pfizer’s vaccine could potentially prevent 90 percent of cases, but the road ahead is still very long and very uncertain.